High-throughput proteomic analysis reveals systemic dysregulation in virally suppressed people living with HIV.
AIDS/HIV
Bioinformatics
Cardiovascular disease
Innate immunity
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
08 06 2023
08 06 2023
Historique:
received:
15
11
2022
accepted:
18
04
2023
medline:
9
6
2023
pubmed:
20
4
2023
entrez:
20
04
2023
Statut:
epublish
Résumé
BACKGROUNDPeople living with HIV (PLHIV) receiving antiretroviral therapy (ART) exhibit persistent immune dysregulation and microbial dysbiosis, leading to development of cardiovascular diseases (CVDs). We initially compared plasma proteomic profiles between 205 PLHIV and 120 healthy control participants (HCs) and validated the results in an independent cohort of 639 PLHIV and 99 HCs. Differentially expressed proteins (DEPs) were then associated to microbiome data. Finally, we assessed which proteins were linked with CVD development in PLHIV.METHODSProximity extension assay technology was used to measure 1,472 plasma proteins. Markers of systemic inflammation (C-reactive protein, D-dimer, IL-6, soluble CD14, and soluble CD163) and microbial translocation (IFABP) were measured by ELISA, and gut bacterial species were identified using shotgun metagenomic sequencing. Baseline CVD data were available for all PLHIV, and 205 PLHIV were recorded for development of CVD during a 5-year follow-up.RESULTSPLHIV receiving ART had systemic dysregulation of protein concentrations, compared with HCs. Most of the DEPs originated from the intestine and lymphoid tissues and were enriched in immune- and lipid metabolism-related pathways. DEPs originating from the intestine were associated with specific gut bacterial species. Finally, we identified upregulated proteins in PLHIV (GDF15, PLAUR, RELT, NEFL, COL6A3, and EDA2R), unlike most markers of systemic inflammation, associated with the presence and risk of developing CVD during 5-year follow-up.CONCLUSIONOur findings suggest a systemic dysregulation of protein concentrations in PLHIV; some proteins were associated with CVD development. Most DEPs originated from the gut and were related to specific gut bacterial species.TRIAL REGISTRATIONClinicalTrials.gov NCT03994835.FUNDINGAIDS-fonds (P-29001), ViiV healthcare grant (A18-1052), Spinoza Prize (NWO SPI94-212), European Research Council (ERC) Advanced grant (grant 833247), and Indonesia Endowment Fund for Education.
Identifiants
pubmed: 37079385
pii: 166166
doi: 10.1172/jci.insight.166166
pmc: PMC10393229
doi:
pii:
Substances chimiques
C-Reactive Protein
9007-41-4
Banques de données
ClinicalTrials.gov
['NCT03994835']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Nat Genet. 2018 Nov;50(11):1524-1532
pubmed: 30250126
J Clin Endocrinol Metab. 2009 Dec;94(12):5155-62
pubmed: 19837927
J Am Heart Assoc. 2019 Jul 16;8(14):e012241
pubmed: 31266386
JAMA Netw Open. 2020 Jun 1;3(6):e207954
pubmed: 32539152
EBioMedicine. 2018 Jan;27:40-50
pubmed: 29269040
Nat Med. 2006 Dec;12(12):1365-71
pubmed: 17115046
Nat Rev Drug Discov. 2008 Jun;7(6):489-503
pubmed: 18511927
J Am Heart Assoc. 2014 Oct 23;3(5):e001118
pubmed: 25341887
J Am Heart Assoc. 2021 Dec 7;10(23):e023330
pubmed: 34845919
Lancet HIV. 2020 Apr;7(4):e279-e293
pubmed: 32243826
Proteomes. 2020 Sep 07;8(3):
pubmed: 32906648
AIDS. 2015 Jan 2;29(1):43-51
pubmed: 25387317
Nat Rev Endocrinol. 2015 Oct;11(10):592-605
pubmed: 26260145
Front Immunol. 2021 Jul 05;12:647805
pubmed: 34290695
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
PLoS Pathog. 2009 Feb;5(2):e1000295
pubmed: 19214220
iScience. 2022 Sep 07;25(10):105089
pubmed: 36157576
Eur Heart J. 2009 May;30(9):1057-65
pubmed: 19168526
J Infect Dis. 2011 Mar 15;203(6):780-90
pubmed: 21252259
Clin Infect Dis. 2010 May 15;50(10):1387-96
pubmed: 20380565
Mol Cell Proteomics. 2021;20:100168
pubmed: 34715355
Nat Rev Endocrinol. 2021 Oct;17(10):592-607
pubmed: 34381196
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Trends Endocrinol Metab. 2020 Dec;31(12):939-951
pubmed: 33172749
Nat Genet. 2020 Oct;52(10):1122-1131
pubmed: 32895551
Eur J Neurol. 2018 Mar;25(3):562-568
pubmed: 29281157
J Immunol. 2008 May 15;180(10):6798-807
pubmed: 18453600
J Infect Dis. 2021 Oct 28;224(8):1405-1409
pubmed: 33606018
Obesity (Silver Spring). 2014 Aug;22(8):1807-13
pubmed: 24719315
J Med Virol. 2008 Feb;80(2):209-16
pubmed: 18098145
J Infect Dis. 2007 Jun 15;195(12):1774-8
pubmed: 17492593
J Virol. 2005 Nov;79(21):13759-68
pubmed: 16227295
Biochem Biophys Res Commun. 2017 Sep 9;491(1):25-32
pubmed: 28688764
Front Immunol. 2021 Apr 19;12:661990
pubmed: 33953724
J Infect Dis. 2020 Aug 17;222(6):929-939
pubmed: 32310273
Mucosal Immunol. 2016 May;9(3):677-88
pubmed: 26376368
EBioMedicine. 2016 Jan 26;4:40-9
pubmed: 26981570
PLoS One. 2010 Nov 15;5(11):e13984
pubmed: 21085593
Curr HIV/AIDS Rep. 2021 Apr;18(2):128-138
pubmed: 33687703
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
HIV Med. 2016 May;17(5):350-7
pubmed: 26365671
PLoS One. 2016 May 12;11(5):e0155100
pubmed: 27171281
J Virol. 2014 Nov;88(22):13015-28
pubmed: 25165117
Curr Opin HIV AIDS. 2010 Mar;5(2):151-7
pubmed: 20543593
J Clin Invest. 2007 Nov;117(11):3148-54
pubmed: 17975656
JCI Insight. 2021 Apr 8;6(7):
pubmed: 33630761
Lancet. 2002 Jun 22;359(9324):2159-63
pubmed: 12090982
Circulation. 2018 Sep 11;138(11):1100-1112
pubmed: 29967196
Eur Heart J. 2016 Apr 21;37(16):1325-33
pubmed: 26417057
Circulation. 2012 Sep 25;126(13):1596-604
pubmed: 22907935
J Clin Med. 2022 Jan 22;11(3):
pubmed: 35160008
Int J Cardiol. 2013 Sep 10;167(6):2904-11
pubmed: 22909410
Biochem Biophys Res Commun. 2015 Sep 18;465(2):275-80
pubmed: 26260321
Metabolites. 2019 Sep 30;9(10):
pubmed: 31574898
Blood. 2012 Aug 16;120(7):1357-66
pubmed: 22653975
Trends Immunol. 2004 Aug;25(8):450-5
pubmed: 15275645
Cell. 2020 Aug 20;182(4):1066-1066.e1
pubmed: 32822569
Nat Med. 2016 Aug 4;22(8):831-3
pubmed: 27490433
J Infect Dis. 2020 Jan 1;221(1):110-121
pubmed: 31504638
F1000Res. 2016 Jul 15;5:1717
pubmed: 27830058
PLoS One. 2014 Feb 11;9(2):e88591
pubmed: 24523921
Neurology. 2017 Nov 14;89(20):2108-2114
pubmed: 29046363
J Infect Dis. 2014 Oct 15;210(8):1228-38
pubmed: 24755434
Lancet Public Health. 2017 Jan;2(1):e35-e46
pubmed: 29249478
JACC Heart Fail. 2015 Aug;3(8):591-9
pubmed: 26164679
Stroke. 2014 Jan;45(1):18-23
pubmed: 24253546
J Autoimmun. 2018 Feb;87:1-15
pubmed: 29275836
J Infect Dis. 2011 Jul 1;204(1):154-63
pubmed: 21628670
PLoS Pathog. 2020 Mar 2;16(3):e1008333
pubmed: 32119719
J Biol Chem. 2002 Nov 22;277(47):44953-61
pubmed: 12270937
Clin Chem. 2017 Jan;63(1):325-333
pubmed: 27811204
Clin Infect Dis. 2018 Apr 3;66(8):1230-1238
pubmed: 29149237
J Infect Dis. 2022 Nov 11;226(10):1809-1822
pubmed: 35535576
Am J Emerg Med. 2019 Jul;37(7):1346-1352
pubmed: 31029521
Medicine (Baltimore). 2018 Feb;97(5):e9759
pubmed: 29384862
Sci Adv. 2021 Jul 28;7(31):
pubmed: 34321199
EBioMedicine. 2015 Nov 22;3:135-140
pubmed: 26870824
Lancet. 2014 Jul 19;384(9939):241-8
pubmed: 25042234
HIV Med. 2013 Apr;14(4):195-207
pubmed: 22998068
Am J Physiol Endocrinol Metab. 2010 Dec;299(6):E1016-27
pubmed: 20841504
J Immunol. 2013 Sep 1;191(5):2164-73
pubmed: 23894197
Front Immunol. 2022 Dec 20;13:982746
pubmed: 36605197
Science. 2015 May 8;348(6235):648-60
pubmed: 25954001
Stroke. 2019 Jul;50(7):1669-1675
pubmed: 31138085
Immunity. 2013 Oct 17;39(4):633-45
pubmed: 24138880
Atherosclerosis. 2018 Apr;271:245-251
pubmed: 29402404
Front Immunol. 2019 Aug 27;10:1965
pubmed: 31507593
Clin Infect Dis. 2014 Dec 15;59(12):1787-97
pubmed: 25182245